RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 82 filers reported holding RECRO PHARMA INC in Q2 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | -100.0% | 12,617 | +4.2% | 0.00% | -50.0% |
| Q1 2021 | $34,000 | -61.8% | 12,104 | -61.1% | 0.00% | -80.0% |
| Q4 2020 | $89,000 | +18.7% | 31,146 | +141.9% | 0.01% | +150.0% |
| Q1 2019 | $75,000 | +4.2% | 12,875 | +27.7% | 0.00% | 0.0% |
| Q4 2018 | $72,000 | -53.8% | 10,080 | -54.0% | 0.00% | -60.0% |
| Q3 2018 | $156,000 | -54.8% | 21,926 | -30.1% | 0.01% | -47.4% |
| Q1 2018 | $345,000 | – | 31,369 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |